Defining the role of SGAs in the long-term treatment of bipolar disorder

Gin S Malhi^{1

2

3}, Grace Morris^{1

2

3}, Amber Hamilton^{1

2

3}, Tim Outhred^{1

2

3}, Pritha Das^{1

2

3}

Affiliations

¹ Academic Department of Psychiatry, Northern Sydney Local Health District, St Leonards, NSW, Australia.
² Sydney Medical School Northern, University of Sydney, Sydney, NSW, Australia.
³ CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia.

Comment

Gin S Malhi et al. Bipolar Disord. 2017 Feb.

. 2017 Feb;19(1):65-67.

doi: 10.1111/bdi.12472.

Gin S Malhi^{1

2

3}, Grace Morris^{1

2

3}, Amber Hamilton^{1

2

3}, Tim Outhred^{1

2

3}, Pritha Das^{1

2

3}

¹ Academic Department of Psychiatry, Northern Sydney Local Health District, St Leonards, NSW, Australia.
² Sydney Medical School Northern, University of Sydney, Sydney, NSW, Australia.
³ CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia.

No abstract available

Keywords: bipolar disorder; maintenance treatment; second-generation antipsychotics.

Comment on

Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
Yatham LN, Beaulieu S, Schaffer A, Kauer-Sant'Anna M, Kapczinski F, Lafer B, Sharma V, Parikh SV, Daigneault A, Qian H, Bond DJ, Silverstone PH, Walji N, Milev R, Baruch P, da Cunha A, Quevedo J, Dias R, Kunz M, Young LT, Lam RW, Wong H. Yatham LN, et al. Mol Psychiatry. 2016 Aug;21(8):1050-6. doi: 10.1038/mp.2015.158. Epub 2015 Oct 13. Mol Psychiatry. 2016. PMID: 26460229 Free PMC article. Clinical Trial.